-

Innovaderm Receives Top Recognition in the CRO Leadership Awards

MONTREAL--(BUSINESS WIRE)--Innovaderm today announced it has been awarded the CRO Leadership Awards. This huge achievement testifies to the excellency and ever-growing presence in the CRO world.

Innovaderm is offering full-service clinical research services, while serving its partners in their journey to discover new dermatology therapies.

Being selected by sponsors as top award winner in the Capabilities category, Innovaderm proves once more being top of mind for drug developers when it comes to selecting a CRO for their phase 1 to 3 with sites in North America and Europe. Other categories where Innovaderm performed in the top are: Expertise, Compatibility, Quality and Reliability.

"These award winners have proven themselves to be the top service providers in each category, said Ed Miseta, chief editor for Clinical Leader. "I congratulate all of them for work ethic they exhibit in consistently meeting the needs of their drug development clients."

The CRO Leadership Awards honours clinical research organizations that meet and exceed customer expectations. For 2021, Clinical Leader and Life Science Leader have once again teamed up with Industry Standard Research (ISR) to determine the winners. Recipients of the awards are vetted against more than 60 CROs and the participants are assessed by sponsor decision makers who have used clinical research services within the past 18 months.

Dr. Robert Bissonnette, Founder and CEO of Innovaderm, commented: “We are very pleased to receive this recognition. It is a tremendous honour to see our work acknowledged by Biotech and Pharma sponsors. At Innovaderm, we pride ourselves in offering niche expertise and quality services and these awards demonstrate that we are able to deliver.”

About Innovaderm

Innovaderm is a full-service contract research organization (CRO) offering support in the management of Phase 1 to 3 trials worldwide. Innovaderm partners with the drug industry to support single and multicenter clinical research & development. For the past 20 years, our team has supported sponsors with their medical, scientific and clinical execution in dermatology trials. To learn more about Innovaderm, please visit us on our website, LinkedIn, or Twitter.

Contacts

Audrey Miron
Innovaderm Research
1-866-575-3111 ext. 274
amiron@innovaderm.com

Innovaderm


Release Summary
Innovaderm receives top recognition in the CRO Leadership Awards

Contacts

Audrey Miron
Innovaderm Research
1-866-575-3111 ext. 274
amiron@innovaderm.com

Social Media Profiles
More News From Innovaderm

Innovaderm Research Rebrands as Indero, a Dual-Focus CRO

MONTREAL--(BUSINESS WIRE)--Innovaderm, a leading clinical research organization (CRO), is excited to reveal a major rebranding to Indero, with immediate effect. The new brand identity reinforces the company’s dual focus on rheumatology and dermatology and recognizes the close synergy between these fields. Innovaderm has over 25 years of clinical research experience within dermatology, and recognizes that many inflammatory and autoimmune conditions manifest across both the skin and the musculosk...

Innovaderm Research, a Dual Focus CRO, Appoints Jeff Smith as New CEO

MONTREAL--(BUSINESS WIRE)--Innovaderm Research, a leader in dermatological and rheumatological research, is proud to announce the appointment of Jeff Smith as the new CEO of the organization. This strategic change allows Innovaderm’s founder and former CEO, Dr. Robert Bissonnette, to fully dedicate himself to his role as Executive Chairman of Innovaderm, providing medical and scientific support to the CRO and its clients. Jeff brings nearly 30 years of experience in the pharmaceutical and CRO i...

Innovaderm Research Appoints Ina Zschocke as New Executive Vice President, European Operations and Strategy

MONTREAL--(BUSINESS WIRE)--Innovaderm, a leading clinical research organization (CRO) specializing in dermatology and rheumatology, is pleased to announce the appointment of Ina Zschocke, as the new Executive Vice President, European Operations and Strategy. This strategic hire underscores Innovaderm’s commitment to expanding its ever-growing presence and capabilities in the European market. Ina Zschocke, PhD, MDRA brings more than 20 years of clinical research expertise, particularly in dermat...
Back to Newsroom